Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucagon RTU for Post-Bariatric Hypoglycemia
NCT03770637Phase 2Completed
- Sponsor
- Xeris Biopharma Holdings, Inc.
- Start
- May 2019
- Primary completion
- Feb 2020
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in post-bariatric hypoglycemia (PBH), sponsored by Xeris Biopharma Holdings, Inc.. Started May 2019; status: completed.
02
Drugs
glucagon
03
Conditions
post-bariatric hypoglycemia (PBH)
Beyond the preview
Go deeper on NCT03770637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770637.